This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Fructosamine Reagents Market

Fructosamine Reagents Market by Disease, End-User & Region - Forecast 2022-2032

Market Insights on Fructosamine Reagents covering sales outlook, demand forecast & up-to-date key trends

Fructosamine Reagents Market Outlook

The fructosamine reagents market is projected to acquire a 4% CAGR during the forecast period 2022-2032.

The higher sales of fructosamine reagents can be attributed to the lesser time-consumption by fructosamine when compared to the glucose concentration provided by haemoglobin.

Attributes

Details

Fructosamine Reagents Market CAGR

4%

Fructosamine Reagents Market Value (2022)

US$ 4.3 Bn

Longer lifespan of glycohemoglobin do not reflect the changes in the glucose concentration more efficiently hence fructosamine is preferred for the measurement of the glucose level in the diabetic patients thereby spiking the demand for fructosamine reagents around the globe.

In addition, the rising sales of fructosamine reagents is also due to the prevalence of diabetes in developed as well as developing countries is increasing due to various factors such as family history of diabetes.

One other major propeller of demand for fructosamine reagents is the widespread obesity (majorly due to change in the lifestyle), as increasing prevalence of diabetes add up to the cost of management of diabetes.

The report sheds light on the factors improving the sales of fructosamine reagents, and, in turn, the opportunities for the market players. However, the fructosamine reagents market also faces some challenges, which might limit the fructosamine market share from reaching its potential.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Fructosamine Reagents Market Dynamics

Increasing prevalence of diabetes across the world expected to drive the demand for fructosamine reagents in coming years.

With severity of the diabetes is on increase and requiring monitoring frequently expected to reflect in the global sales of fructosamine reagents.

With need for frequent and real time monitoring of the glucose level among diabetes patients is increasing the fructosamine reagents provides exact mechanism which in turn expected to boost the sales of fructosamine reagents.

The demand for fructosamine reagents is on the surge also due to the widespread availability of the fructosamine reagents is expected to scale up the sales of fructosamine reagents.

Increasing per capita expenditure on the evaluating the glucose level testing provides impetus to the overall demand for fructosamine reagents.

Whereas, economic nature of HbA1C test is the prime impediment to the growing sales of fructosamine reagents in various countries thereby dwindling the fructosamine reagents market share.

However, increasing number of global and regional fructosamine reagents manufacturers expected to augment the demand for fructosamine reagents for glucose monitoring, in turn, peaking the sales of fructosamine reagents.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Regions Holds a Sway in the Fructosamine Reagents Market

North America is expected to witness the highest demand for fructosamine reagents in the global fructosamine reagents market owing to higher prevalence of the diabetes.

Latin America fructosamine reagents market is expected to witness steady rise in the sales of fructosamine reagents during the forecast period owing to increasing product availability in the region.

Europe fructosamine reagents market is exhibit second most lucrative region in terms of sales of fructosamine reagents due to higher adoption of fructosamine test assays.

Asia-Pacific is projected to experience growing demand for fructosamine reagents owing to increasing diagnosed prevalence of diabetes in the region.

Middle East & Africa fructosamine reagents market is expected witness the least demand for fructosamine reagents on account of lower product availability in the region.

Who are Some of the Notable Players in the Fructosamine Reagents Market

The key participants operating in the global fructosamine reagents market are: Randox Laboratories Ltd., Sekisui Diagnostics, Biosystems S.A., Kamiya Biomedical Co., Sentinel Diagnostics, Asahi Kasei Pharma Corporation, and others.

The report consists of key players, contributing to the fructosamine reagents market share. It also consists of organic and inorganic growth strategies adopted by market players to improve their market positions thereby augmenting the demand for fructosamine reagents worldwide.

This exclusive report analysis the competitive landscape and fructosamine reagents market share acquired by players to strengthen their market position.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Report Scope

Report Attribute

Details

Base year for estimation

2021

Historical data

2015 - 2020

Forecast period

2022 - 2032

Quantitative units

Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032

Report coverage

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis

Segments covered

Disease, End Use, Region

Regional scope

North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand

Country scope

U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa

Key companies profiled

Randox Laboratories Ltd., Sekisui Diagnostics, Biosystems S.A., Kamiya Biomedical Co., Sentinel Diagnostics, Asahi Kasei Pharma Corporation, and others.

Customization scope

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs.

Frequently Asked Questions

North America is expected to hold the highest demand for fructosamine reagents market share owing to higher prevalence of the diabetes.

Randox Laboratories Ltd., Sekisui Diagnostics, Biosystems S.A., Kamiya Biomedical Co., Sentinel Diagnostics are a few key players.

Economic nature of HbA1C test is the prime impediment to the growing demand for fructosamine reagents in various countries.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Fructosamine Reagents Market